Hydroxyzine inhibits neurogenic bladder mast cell activation

Area of Science:

• Urology
• Pharmacology
• Immunology

Background:

• Interstitial cystitis (IC) is a chronic bladder condition characterized by pain and inflammation, often linked to mast cell activation.
• Patients with IC frequently experience comorbidities like allergies, yet standard antihistamines provide limited relief.
• Mast cells in IC bladders are activated by neurogenic stimuli such as acetylcholine (Ach) and stress, exacerbating symptoms.

Purpose of the Study:

• To investigate the potential of hydroxyzine, a histamine-1 receptor antagonist (H-1r alpha), in inhibiting carbachol-induced bladder mast cell activation.
• To explore the mechanism by which hydroxyzine affects mast cell degranulation in the context of IC.

Main Methods:

• Rat bladder tissue was perfused with carbachol, substance P (SP), or compound 48/80 (C48/80).
• Mast cell activation was measured by the release of 3H-serotonin and observed via light microscopy.
• Tissues were preincubated with varying concentrations of hydroxyzine or other H-1r alpha agents.

Main Results:

• Carbachol significantly increased mast cell serotonin release (65% over control).
• Hydroxyzine demonstrated a dose-dependent inhibition of carbachol-induced serotonin release (25% at 10(-6) M, 34% at 10(-5) M, P < 0.05).
• Diphenhydramine showed no inhibitory effect, while azatadine increased serotonin release.

Conclusions:

• Hydroxyzine inhibits carbachol-induced mast cell activation in rat bladders via a non-H-1 receptor antagonistic mechanism.
• Hydroxyzine's mast cell inhibitory effects, combined with its anticholinergic and anxiolytic properties, may explain its efficacy in treating IC symptoms.
• Development of non-sedating hydroxyzine analogs could offer new therapeutic avenues for interstitial cystitis.